{"created":"2015-05-15T13:32:19+00:00","modified":"2015-05-15T13:32:19+00:00","valid":{"from":"2013-04-01T09:56:23+00:00","to":"3013-04-01T09:56:23+00:00"},"hreflang":"en","guid":"83e9d0cd-d0cf-4919-892a-605b97a088e6","teaser":"The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.","published":"2013-04-01T09:56:23+00:00","tags":["APM","Health Care","India","cancer","health care","pharmaceuticals"],"byline":"Rahul Tandon","description":"The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.","itags":["Marketplace","Marketplace Morning Report","PMP:Marketplace_PMP","Marketplace Morning Report for Monday, April 1, 2013","83e9d0cdd0cf919a92a7605b97a088e6"],"title":"India rejects Novartis cancer drug patent","contenttemplated":"[{\"content\":\"<p>The Supreme Court in India has <a href=\\\"http://www.bloomberg.com/news/2013-04-01/novartis-cancer-drug-patent-denied-by-india-supreme-court.html\\\" target=\\\"_blank\\\">rejected an attempt</a> by the Swiss drug maker Novartis to patent an update to a cancer treatment called Gleevec -- spelled Glivec in some markets. The decision is expected to have a big impact on pharmaceutical companies and health organizations far outside the borders of India.</p>\",\"type\":\"text/html\"},{\"type\":\"text/html\",\"content\":\"<p>The BBC&apos;s Rahul Tandon joins Marketplace Morning Report host Jeremy Hobson to discuss the global pharmaceutical market and the new patent ruling.</p>\"}]","contentencoded":"<div class=\"barn-cleaned\"><p>The Supreme Court in India has <a href=\"http://www.bloomberg.com/news/2013-04-01/novartis-cancer-drug-patent-denied-by-india-supreme-court.html\" target=\"_blank\">rejected an attempt</a> by the Swiss drug maker Novartis to patent an update to a cancer treatment called Gleevec -- spelled Glivec in some markets. The decision is expected to have a big impact on pharmaceutical companies and health organizations far outside the borders of India.</p>\n<p>The BBC's Rahul Tandon joins Marketplace Morning Report host Jeremy Hobson to discuss the global pharmaceutical market and the new patent ruling.</p></div>","audio":[{"type":"image/jpeg","meta":{"crop":"primary","height":"340","width":"610"},"href":"http://www.marketplace.org/sites/default/files/styles/primary-image-610x340/public/158610482.jpg?itok=7-9T4C0A"},{"type":"audio/mpeg","meta":{"duration_hms":"00:02:24","api":{"type":"application/json","href":"http://api.publicradio.org/audio/v2?ref=pmp&id=apm-audio:/marketplace/segments/2013/04/01/marketplace_segment03_20130401"},"duration":144},"format":"MP3","href":"http://play.publicradio.org/pmp/d/podcast/marketplace/segments/2013/04/01/marketplace_segment03_20130401_64.mp3"}]}